NO302366B1 - 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat - Google Patents
4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparatInfo
- Publication number
- NO302366B1 NO302366B1 NO944430A NO944430A NO302366B1 NO 302366 B1 NO302366 B1 NO 302366B1 NO 944430 A NO944430 A NO 944430A NO 944430 A NO944430 A NO 944430A NO 302366 B1 NO302366 B1 NO 302366B1
- Authority
- NO
- Norway
- Prior art keywords
- mercaptoacetylamino
- benzazepinone
- derivatives
- pharmaceutical preparation
- enkephalinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/886,029 US5238932A (en) | 1992-05-20 | 1992-05-20 | Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
PCT/US1993/003150 WO1993023397A1 (fr) | 1992-05-20 | 1993-04-06 | Derives de 4-mercaptoacetylamino-[2] benzazepinone(3) et leur utilisation en tant qu'inhibiteurs de l'encephalinase |
Publications (3)
Publication Number | Publication Date |
---|---|
NO944430D0 NO944430D0 (no) | 1994-11-18 |
NO944430L NO944430L (no) | 1995-01-17 |
NO302366B1 true NO302366B1 (no) | 1998-02-23 |
Family
ID=25388225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944430A NO302366B1 (no) | 1992-05-20 | 1994-11-18 | 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat |
Country Status (20)
Country | Link |
---|---|
US (1) | US5238932A (fr) |
EP (1) | EP0641343B1 (fr) |
JP (1) | JP3295848B2 (fr) |
KR (1) | KR100281608B1 (fr) |
AT (1) | ATE243694T1 (fr) |
AU (1) | AU669716B2 (fr) |
CA (1) | CA2135751C (fr) |
DE (1) | DE69333062T2 (fr) |
DK (1) | DK0641343T3 (fr) |
ES (1) | ES2201058T3 (fr) |
FI (1) | FI108136B (fr) |
HU (1) | HUT71107A (fr) |
IL (1) | IL105727A (fr) |
MX (1) | MX9302906A (fr) |
NO (1) | NO302366B1 (fr) |
NZ (1) | NZ252785A (fr) |
PT (1) | PT641343E (fr) |
TW (1) | TW269682B (fr) |
WO (1) | WO1993023397A1 (fr) |
ZA (1) | ZA933423B (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5430145A (en) * | 1990-10-18 | 1995-07-04 | Merrell Dow Pharmaceuticals Inc. | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
US5308841A (en) * | 1990-12-21 | 1994-05-03 | Merrell Dow Pharmaceuticals Inc. | Amino and nitro containing tricyclic compounds useful as inhibitors of ACE |
US5455242A (en) * | 1991-09-27 | 1995-10-03 | Merrell Dow Pharmaceuticals Inc. | Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace |
ES2106112T3 (es) * | 1991-09-27 | 1997-11-01 | Merrell Pharma Inc | Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace. |
ZA927211B (en) * | 1991-09-27 | 1993-03-24 | Merrell Dow Pharma | Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE. |
US5457196A (en) * | 1991-09-27 | 1995-10-10 | Merrell Dow Pharmaceuticals Inc. | 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
ES2117123T3 (es) * | 1992-02-14 | 1998-08-01 | Merrell Pharma Inc | Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina. |
US5420271A (en) * | 1992-08-24 | 1995-05-30 | Merrell Dow Pharmaceuticals, Inc. | 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
DE69329701T2 (de) * | 1992-10-30 | 2001-05-10 | Merrell Pharma Inc | Mercaptoacetylamid substituiertes bizyclisches laktam zur verwendung als enkephalinase und ace-hemmer |
KR0156780B1 (ko) * | 1993-06-11 | 1998-11-16 | 나이토 하루오 | 아미노산 유도체 |
AU680512B2 (en) * | 1993-06-11 | 1997-07-31 | Eisai Co. Ltd. | Amino acid derivative |
US5530013A (en) * | 1994-02-14 | 1996-06-25 | American Home Products Corporation | Venlafaxine in the inducement of cognition enhancement |
EP0746566A1 (fr) * | 1994-02-14 | 1996-12-11 | Merrell Pharmaceuticals Inc. | Nouveaux derives bisulfure d'idane-2-mercaptoacetylamides substitues en position 2, utiles comme inhibiteurs de l'encephalinase et de l'enzyme de conversion de l'angiotensine (ace) |
JP3596778B2 (ja) * | 1994-02-14 | 2004-12-02 | メレル ファーマスーティカルズ インコーポレーテッド | エンケファリナーゼ及びaceの阻害剤として有用な、新規なメルカプトアセチルアミドジスルフィド誘導体類 |
JPH09508906A (ja) * | 1994-02-14 | 1997-09-09 | メレル ファーマスーティカルズ インコーポレーテッド | エンケファリナーゼ及びaceの阻害剤として有用な新規なメルカプトアセチルアミド1,3,4,5−テトラヒドロベンゾ[c]アゼピン−3−オンジスルフィド誘導体類 |
HUT74584A (en) * | 1994-02-14 | 1997-01-28 | Merrell Pharma Inc | Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them |
US5484783A (en) * | 1994-03-24 | 1996-01-16 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives |
HUT75160A (en) * | 1994-03-24 | 1997-04-28 | Merrell Pharma Inc | Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
CN1144482A (zh) * | 1994-03-24 | 1997-03-05 | 默里尔药物公司 | 降低胆固醇、抗动脉粥样硬化和降低甘油三酯的巯基乙酰胺二硫化物衍生物 |
US5641880A (en) * | 1994-12-21 | 1997-06-24 | Hoechst Marion Roussel, Inc. | Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
ATE266040T1 (de) * | 1994-12-21 | 2004-05-15 | Aventis Pharma Inc | Verfahren zur herstellung von zwischenprodukten von inhibitoren von enkephalinase und angiotensin konvertierendem enzym und zwischenprodukte davon |
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
US6635632B1 (en) * | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
IT1298268B1 (it) * | 1998-02-18 | 1999-12-20 | Zambon Spa | Procedimento per la preparazione dell'acido (s)-2-bromo-3-fenil- propionico |
US6774125B2 (en) * | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6569851B1 (en) * | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
AU2502700A (en) * | 1999-01-12 | 2000-08-01 | Kenneth Blum | Treatment of hypertension with compounds that inhibit the destruction of enkephalins or endorphins |
US7060467B2 (en) * | 2000-03-13 | 2006-06-13 | Monsanto Technology Llc | Recombinant proteins containing repeating units |
GB0119305D0 (en) | 2001-04-12 | 2001-10-03 | Aventis Pharma Gmbh | Mercaptoacetylamide derivatives,a process for their preparation and their use |
US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
CN116535304A (zh) * | 2023-03-31 | 2023-08-04 | 中国科学院成都生物研究所 | 毛兰素类似物及其合成方法和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4415496A (en) * | 1981-03-23 | 1983-11-15 | Merck & Co., Inc. | Bicyclic lactams |
ZA833214B (en) * | 1982-05-12 | 1983-12-28 | Hoffmann La Roche | Bicyclic compounds |
GB2128984B (en) * | 1982-05-12 | 1985-05-22 | Hoffmann La Roche | Diaza-bicyclic compounds |
US4584294A (en) * | 1984-11-07 | 1986-04-22 | Merck & Co., Inc. | Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents |
JPH0678531B2 (ja) * | 1986-06-11 | 1994-10-05 | 株式会社日立製作所 | 石炭ガス化方法及び装置 |
US4973585A (en) * | 1986-06-13 | 1990-11-27 | Merrell Dow Pharmaceuticals | Tricyclic lactams active as antihypertensive agents |
CA1337654C (fr) * | 1986-06-13 | 1995-11-28 | Gary A. Flynn | Lactames tricycliques fondus servant d'agents antihypertenseurs |
ZA874106B (en) * | 1986-06-13 | 1987-12-08 | Merrell Dow Pharmaceuticals Inc. | Novel antihypertensive agent |
US4824832A (en) * | 1987-12-30 | 1989-04-25 | Merrell Dow Pharmaceuticals Inc. | Sulfhydryl containing tricyclic lactams and their pharmacological methods of use |
GB8926512D0 (en) * | 1989-11-23 | 1990-01-10 | Pfizer Ltd | Therapeutic agents |
WO1991009840A1 (fr) * | 1989-12-22 | 1991-07-11 | Schering Corporation | Inhibiteurs aminoacides mercaptocycloacyliques d'endopeptidase |
CA2053340C (fr) * | 1990-10-18 | 2002-04-02 | Timothy P. Burkholder | Derives de mercaptoacetylamide utiles comme inhibiteurs de l'encephalinase et de l'ace |
-
1992
- 1992-05-20 US US07/886,029 patent/US5238932A/en not_active Expired - Fee Related
-
1993
- 1993-04-06 HU HU9403323A patent/HUT71107A/hu unknown
- 1993-04-06 WO PCT/US1993/003150 patent/WO1993023397A1/fr active IP Right Grant
- 1993-04-06 CA CA002135751A patent/CA2135751C/fr not_active Expired - Fee Related
- 1993-04-06 JP JP52021093A patent/JP3295848B2/ja not_active Expired - Fee Related
- 1993-04-06 DK DK93912116T patent/DK0641343T3/da active
- 1993-04-06 DE DE69333062T patent/DE69333062T2/de not_active Expired - Fee Related
- 1993-04-06 KR KR1019940704127A patent/KR100281608B1/ko not_active IP Right Cessation
- 1993-04-06 ES ES93912116T patent/ES2201058T3/es not_active Expired - Lifetime
- 1993-04-06 AT AT93912116T patent/ATE243694T1/de not_active IP Right Cessation
- 1993-04-06 EP EP93912116A patent/EP0641343B1/fr not_active Expired - Lifetime
- 1993-04-06 PT PT93912116T patent/PT641343E/pt unknown
- 1993-04-06 AU AU42779/93A patent/AU669716B2/en not_active Ceased
- 1993-04-06 NZ NZ252785A patent/NZ252785A/en not_active IP Right Cessation
- 1993-05-17 ZA ZA933423A patent/ZA933423B/xx unknown
- 1993-05-18 TW TW082103913A patent/TW269682B/zh active
- 1993-05-18 IL IL10572793A patent/IL105727A/xx not_active IP Right Cessation
- 1993-05-19 MX MX9302906A patent/MX9302906A/es not_active IP Right Cessation
-
1994
- 1994-11-18 NO NO944430A patent/NO302366B1/no unknown
- 1994-11-18 FI FI945434A patent/FI108136B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU9403323D0 (en) | 1995-02-28 |
DE69333062D1 (de) | 2003-07-31 |
ATE243694T1 (de) | 2003-07-15 |
CA2135751C (fr) | 1999-09-21 |
EP0641343B1 (fr) | 2003-06-25 |
FI945434A0 (fi) | 1994-11-18 |
ES2201058T3 (es) | 2004-03-16 |
NO944430D0 (no) | 1994-11-18 |
EP0641343A1 (fr) | 1995-03-08 |
NO944430L (no) | 1995-01-17 |
NZ252785A (en) | 1995-11-27 |
TW269682B (fr) | 1996-02-01 |
US5238932A (en) | 1993-08-24 |
CA2135751A1 (fr) | 1993-11-25 |
DK0641343T3 (da) | 2003-10-13 |
FI945434A (fi) | 1994-11-18 |
HUT71107A (en) | 1995-11-28 |
JPH07506827A (ja) | 1995-07-27 |
FI108136B (fi) | 2001-11-30 |
JP3295848B2 (ja) | 2002-06-24 |
ZA933423B (en) | 1993-12-08 |
KR100281608B1 (ko) | 2001-02-15 |
IL105727A0 (en) | 1993-09-22 |
AU4277993A (en) | 1993-12-13 |
AU669716B2 (en) | 1996-06-20 |
PT641343E (pt) | 2003-10-31 |
IL105727A (en) | 2000-11-21 |
DE69333062T2 (de) | 2004-05-06 |
KR950701632A (ko) | 1995-04-28 |
WO1993023397A1 (fr) | 1993-11-25 |
MX9302906A (es) | 1993-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO302366B1 (no) | 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat | |
NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
NO942994L (no) | Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE | |
MX9206851A (es) | Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene. | |
NL980012I2 (nl) | Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen. | |
FI940769A (fi) | Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi | |
FI953899A (fi) | Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi | |
IS3814A (is) | Aðferð til framleiðslu á lyfjablöndum | |
ITTO930346A0 (it) | Procedimento per la preparazione di derivati taurocolanici. | |
NO964238D0 (no) | Halofantrin-fri-base for behandling av malaria og blandinger | |
IT1247796B (it) | Derivati arilvinilamidici e procedimento per la loro preparazione | |
IT1233446B (it) | Derivati della 3 piperidinocarbaldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci | |
LV11463A (lv) | Aizvietotu 4,6-diamino-5-cianpirimidinu iegusanas panemiens | |
FI953361A (fi) | Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi | |
DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
HUT65256A (en) | Process for producing 2-mercapto methylene-tetrahydronaphtalene-2-carboxamide derivatives and pharmaceutical preparations containing them | |
ITTO930667A0 (it) | Procedimento per la preparazione di ethalfluralin | |
DK0703916T3 (da) | 14-Substituerede marcfortiner og derivater, der kan anvendes som antispirant-midler | |
NO883987L (no) | Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter. | |
ITMI931174A0 (it) | Composizioni farmaceutiche per la cura della talassemia | |
ITMI931684A0 (it) | Procedimento per la preparazione di derivati del 5,4- diidrocarbostirile | |
NO924276L (no) | Fremgangsmaate for fremstilling av laktonet av 1r,cis-2,2-dimethyl-3-formyl-cyclopropan-1-karboksylsyre og mellomprodukter for anvendelse ved fremgangsmaaten | |
MX9102492A (es) | Procedimiento para la determinacion del origen de bebidas espirituosas. | |
MX9101841A (es) | Derivados de ciclosporina, proceso para su produccion y composicion farmaceutica que los contiene | |
NO302413B1 (no) | Fremgangsmåte for fremstilling av form 1 ranitidinhydroklorid |